Rob Surgical has joined CataloniaBio, the Catalan association of biomedical and healthcare companies that acts as a lobby and key entity for B2B synergies, internationalisation and attracting investors. The entity interviewed Jaume Amat, CEO of Rob Surgical and member of the current board of directors of CataloniaBio, who explained the key points of Bitrack, the new system for minimally invasive surgery, designed and developed with top specialists from Catalonia and the United States.
Read the interview (available in Catalan): “With the new Bitrack® robot surgery will be more comfortable and precise”
